Both in Pharmaceuticals
Genelux vs Aardvark Therapeutics
Over the past year GNLX returned −39.8% and AARD returned −60.3%; their daily moves had a correlation of 0.14.
GNLX −39.8% AARD −60.3%Growth of $1, one year, split-adjusted
| Metric | GNLX | AARD |
|---|---|---|
| Price | $2.53 | $5.27 |
| Market cap | $114.5M | $115.3M |
| Today | +3.27% | −1.50% |
| 1 month | −3.3% | −13.6% |
| 6 months | +4.5% | +39.8% |
| Year to date | −42.0% | −59.8% |
| 1 year | −40.5% | −61.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 14,308.8× | — |
| Net cash | $18.7M | $73.9M |
| Dividend yield | — | — |
| Volatility (60d) | 54.1% | 146.4% |
| Short % of float | 10.7% | 3.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).